1[1]Clay TM,Hobeika AC,Mosca PJ,et al.Assays for monitoring cellular immune responses to active immunotherapy of cancer[J].Clin Cancer Res,2001,7: 1127-1135.
2[2]Whiteside TL.Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapy[J].Clin Diagn Lab Immunol,2000,7:327-332.
3[3]Pannetier C,Even J,Kourilsky P.T-cell repertoire diversity and clonal expansions in normal and clinical samples[J].Immunol Today,1995,16:176-181.
4[4]Romero P,Gervois N,Schneider J,et al.Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma[J].J Immunol,1997,159: 2366-2372.
5[5]Whelan JA,Dunbar PR,Price DA,et al.Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent[J].J Immunol,1999,163:4342-4348.
6[6]Mackensen A,Veelken H,Lahn M,et al.Induction of tumor-specific cytotoxic T lymphocytes by immunization with autologous tumor cells and interleukin-2 gene transfected fibroblasts[J].J Mol Med,1997,75: 290-296.
7[7]Altman JD,Moss PAH,Goulder PJR,et al.Phenotypic analysis of antigen-specific T lymphocytes[J].Science,1996,274:94-96.
8[8]Lebowitz MS,O ' Herrin SM,Hamad AR,et al.Soluble,high-affinity dimers of T-cell receptors and class II major histocompatibility complexes: biochemical probes for analysis and modulation of immune responses[J].Cell Immunol,1999,192:175-184.
9[9]Bodinier M,Peyrat MA,Tournay C,et al.Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding[J].Nat Med,2000,6:707-710.
10[10]Jger E,Nagata Y,Gnjatic S,et al.Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses[J].Proc Natl Acad Sci USA,2000,97:4760-4765.
2Joplin RE,Neuberger JM.Immunopathology of primary biliary cirrhosis[J].Eur J Gastroenterol Hepatol,1999,11(6):587-593.
3Matsumura S,Kita H,He X-S,et al.Comprehensive mapping of HLA-A*0201-restricted CD8 T-cell epitopes on PDC-E2 in primary biliary cirrhosis[J].Hepatology,2002,36:1125-1134.
4Pares A,Rodes J.Natural history of primary biliary cirrhosis[J].Clin Liver Dis,2003,7(4):779-794.
5Whelan JA,Dunbar PR,Price DA,et al.Specificity of CTL interactions with peptide-MHC class I tetrameric complex is temperature dependent[J].J Immunol,1999,163:4342-4348.
6Tinmouth J,Lee M,Wanless IR,et al.Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis[J].Liver,2002,22:228-234.
7Shimoda S,Van de Water J,Ansari A,et al.Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis[J].J Clin Invest,1998,102:1831-1840.
8Kita H,Matsumura S,He X-S,et al.Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis[J].J Clin Invest,2002,109:1231-1240.
